Aquestive up on positive FDA feedback for allergy drug

Aquestive Therapeutics

11/10/2022 14:07

** Drug maker Aquestive Therapeutics Inc's shares  AQST.O 
rise 2.94% to $1.05 premarket
    ** Aquestive says got positive feedback from U.S. FDA for
its allergy drug candidate, AQST-109, after meeting  urn:newsml:reuters.com:*:nGNX97sgZM
    ** AQST seeks another meeting for guidance on drug's
clinical components
    ** Stock has gained over 2% only twice in the past month
    ** Up to Monday's close, stock had fallen ~74% YTD
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))